Many of the drugs did not meet FDA labelling requirements including a warning that indicates a drug has a risk of serious or life-threatening effects.
VIRGINIA, United States, Monday November 11, 2013, CMC – The United States Immigration and Customs Enforcement (ICE) agency says the Barbadian co-owner of an international drug company has pleaded guilty to selling misbranded drugs.
ICE said Talib Khan, 42, who is also co-founder of Gallant Pharma International, Inc. “pleaded guilty to selling misbranded chemotherapy and cosmetic drugs, and conspiracy to commit importation fraud, sell misbranded drugs, distribute prescription drugs without a license, and defraud the FDA (US Food and Drug Administration)”.
Read more:
No comments:
Post a Comment